The Latin America, Middle East and Africa Microwave Ablation Market should witness market growth of 17.4% CAGR during the forecast period (2022-2028).
Microwave ablation is a unique technique with various theoretical benefits over previously existing ablation techniques. This includes the generation of larger ablation zones within less time. Further, microwave technology is also efficient with high-impedance tissues, which could be a challenge for other ablation technologies. Usually, microwave ablation is conducted as an outpatient procedure. The clinical utilization of microwave ablation is growing rapidly because of its potential advantages over other therapies such as radiofrequency ablation systems.
Microwave tumor ablation technology has been growing fast over the past few years and is currently being used in the treatment of various types of cancers. The growing demand for microwave ablation could be attributed to increased funding from the private sector for the development of the latest microwave ablation product.
As per the data provided by WHO, around 10-11 million cases are predicted to be diagnosed each year till 2030. The occurrence of new cancer cases is more in low-income nations, which has increased by more than 80 percent in comparison to the nations with high-income level. Furthermore, patients with hectic schedules wish to cut short the hospital stay period and thus are demanding minimally invasive therapies with less recovery period.
The growing aging population in the region is resulting in rising occurrences of cardiovascular diseases. As per the Statistics, South Africa’s most recent mid-year population, the nation has approximately 56.5 million people. In addition, the elderly population in the country with age 60 and above is continuously grooving and reached 8.1% of the total population in 2017. The growing aging population in the region is resulting in rising occurrences of cardiovascular diseases. All these elements are estimated to support the market growth of microwave ablation in the LAMEA region.
The Brazil market dominated the LAMEA Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $12,189.8 Thousands by 2028. The Argentina market is showcasing a CAGR of 18% during (2022-2028). Additionally, The UAE market would register a CAGR of 17% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Microwave ablation is a unique technique with various theoretical benefits over previously existing ablation techniques. This includes the generation of larger ablation zones within less time. Further, microwave technology is also efficient with high-impedance tissues, which could be a challenge for other ablation technologies. Usually, microwave ablation is conducted as an outpatient procedure. The clinical utilization of microwave ablation is growing rapidly because of its potential advantages over other therapies such as radiofrequency ablation systems.
Microwave tumor ablation technology has been growing fast over the past few years and is currently being used in the treatment of various types of cancers. The growing demand for microwave ablation could be attributed to increased funding from the private sector for the development of the latest microwave ablation product.
As per the data provided by WHO, around 10-11 million cases are predicted to be diagnosed each year till 2030. The occurrence of new cancer cases is more in low-income nations, which has increased by more than 80 percent in comparison to the nations with high-income level. Furthermore, patients with hectic schedules wish to cut short the hospital stay period and thus are demanding minimally invasive therapies with less recovery period.
The growing aging population in the region is resulting in rising occurrences of cardiovascular diseases. As per the Statistics, South Africa’s most recent mid-year population, the nation has approximately 56.5 million people. In addition, the elderly population in the country with age 60 and above is continuously grooving and reached 8.1% of the total population in 2017. The growing aging population in the region is resulting in rising occurrences of cardiovascular diseases. All these elements are estimated to support the market growth of microwave ablation in the LAMEA region.
The Brazil market dominated the LAMEA Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $12,189.8 Thousands by 2028. The Argentina market is showcasing a CAGR of 18% during (2022-2028). Additionally, The UAE market would register a CAGR of 17% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Scope of the Study
By End-user
- Hospital
- Research Laboratories
- Ambulatory Surgical Centers
By Component
- Accessories
- Generator
- Power Distribution System
By Application
- Oncology
- Cardiology
- Urology
- Orthopedic
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Microwave Ablation Market by End-user
Chapter 5. LAMEA Microwave Ablation Market by Component
Chapter 6. LAMEA Microwave Ablation Market by Application
Chapter 7. LAMEA Microwave Ablation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Methodology
LOADING...
